Avinger Inc. (AVGR)

Name: Avinger Inc. (AVGR) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Avinger Inc. (AVGR)

Stock Card

$0.47

$0.00 (0.00%)

As on 02-Jul-2025 09:30EDT

Market cap

$2 Mln

Revenue (TTM)

$7 Mln

P/E Ratio

P/B Ratio

0.4

Div. Yield

0 %

Avinger (AVGR) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.47 High: 0.47

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-14.8 %
ROCE

-- %
Industry P/E

44.46
EV/EBITDA

-0.4
Debt to Equity

0
Book Value

$--
EPS

$-12
Face value

--
Shares outstanding

3,196,970

10 Years Aggregate

CFO

$-247.68 Mln

EBITDA

$-260.53 Mln

Net Profit

$-307.76 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Avinger (AVGR)	-42.1	0.0	0.0	-72.0	-72.3	-65.7	-77.7
BSE Sensex^*	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 02-Jul-2025 | *As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2024	2023	2021	2020	2019	2018
Avinger (AVGR)	-69.5	-83.3	2.2	-61.4	-62.0	-95.8
S&P Small-Cap 600	7.0	13.9	25.3	9.6	20.9	-9.7
BSE Sensex	8.1	18.7	22.0	15.8	14.4	5.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About Avinger (AVGR)

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and... Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California. Read more

President, CEO & Director

Mr. Jeffrey M. Soinski
President, CEO & Director

Mr. Jeffrey M. Soinski
Headquarters

Redwood City, CA
Website

https://avinger.com

FAQs for Avinger (AVGR)

What is the current share price of Avinger Inc (AVGR) Today?

The share price of Avinger Inc (AVGR) is $0.47 (NASDAQ) as of 02-Jul-2025 09:30 EDT. Avinger Inc (AVGR) has given a return of -72.26% in the last 3 years.

What is the current PB & PE ratio of Avinger Inc (AVGR)?

Since, TTM earnings of Avinger Inc (AVGR) is negative, P/E ratio is not available.
The P/B ratio of Avinger Inc (AVGR) is 0.39 times as on 02-Jul-2025, a 90 discount to its peers’ median range of 3.79 times.

PE & PB ratio at the end of financial year.